Covidien Public Limited Company, formerly Covidien Ltd. is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company operates in three business segments: medical devices, pharmaceuticals and medical supplies. The medical devices segment includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, products used in vascular therapies and other medical products. The pharmaceuticals segment includes the development, manufacture and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, specialty chemicals, contrast products and radiopharmaceuticals. The medical supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products (OEM).
Quick Financial Synopsis
BRIEF: For the fiscal year ended 25 September 2009, Covidien PLC's revenues increased 3% to $10.68B. Net income from continuing operations decreased 41% to $902M. Revenues reflect an increase in income from medical devices and higher revenue from pharmaceutical product segment. Net income was offset by an increase in selling, general & administration expenses and higher research & development expenses.
Company Address
Covidien plc.
Block G, First Floor Cherrywood Business Park Co. Dublin